What's new

Human medicines European public assessment report (EPAR): Lumeblue (previously Methylthioninium chloride Cosmo), methylthioninium chloride, Date of authorisation: 19/08/2020, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Lumeblue (previously Methylthioninium chloride Cosmo), methylthioninium chloride, Date of authorisation: 19/08/2020, Revision: 5, Status: Authorised

Jun 17, 2025 - 15:05
 0
Human medicines European public assessment report (EPAR): Lumeblue (previously Methylthioninium chloride Cosmo), methylthioninium chloride, Date of authorisation: 19/08/2020, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Lumeblue (previously Methylthioninium chloride Cosmo), methylthioninium chloride, Date of authorisation: 19/08/2020, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Xevudy, sotrovimab, Da...

Next Article

China's burgeoning drone arsenal shows power of civil-military fusion

Related Posts

Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Faslodex, fulvestrant, Date of authorisation: 09/03/2004, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Annexes - 2024 annual report of the European Medicines ...

Jun 10, 2025  0